NL-OMON28884招募中不适用
Safety of TKI concurrent with cranial radiotherapy in NSCLC patients; the SATIN platform trial
Maastricht UMC+<br>PO Box 5800 6202 AZ Maastricht<br>The Netherlands0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •To be eligible to participate in this study, a patient must meet all of the following criteria:
- •-Stage IV NSCLC with driver mutation, treated with TKI, development of brain metastases during TKI treatment
排除标准
- •A potential patient who meets any of the following criteria will be excluded from participation in this study:
- •-Prior radiotherapy to the brain when this precludes new radiotherapy.
研究者
相似试验
招募中
4 期
Safety of TKI concurrent with cranial radiotherapy in NSCLC patients; the SATIN platform trialnon-small cell lung cancer brain metastases10006288NL-OMON54721Medisch Universitair Ziekenhuis Maastricht200
招募中
不适用
Safety and efficacy of intracranial radiotherapy under immunotherapy against CNS metastases of extensive-stage small cell lung cancer in the real-world setting.ung CancerJPRN-UMIN000041879Osaka International Cancer Institute40
招募中
1 期
eoadjuvant Radiotherapy (N-RT) for Intracerebal Metastases of Solid TumorsC79.3Secondary malignant neoplasm of brain and cerebral meningesDRKS00016613Klinik für Radioonkologie, Klinikum rechts der Isar, TU München48
招募中
1 期
Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal AdenocarcinomaPancreatic CancerNCT06141031Washington University School of Medicine24
尚未招募
不适用
Efficacy and safety of transcranial direct current stimulation for obsessive-compulsive patientsKCT0004940Hallym University60